4.5 Article

Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients

Related references

Note: Only part of the references are listed.
Article Immunology

COVID-19 in Lung Transplant Recipients

Jonathan Messika et al.

Summary: The COVID-19 infection in the French cohort of lung transplant patients was severe, with most cases requiring hospitalization and a survival rate of 85.7%. Among the critically ill patients, invasive mechanical ventilation was required for over half, and thrombotic events occurred in 4 patients. Overweight was significantly associated with the risk of death.

TRANSPLANTATION (2021)

Article Surgery

COVID-19 in lung transplant recipients: A single center case series from New York City

Meghan Aversa et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Review Immunology

COVID-19 in lung transplant recipients

Catherine N. Myers et al.

TRANSPLANT INFECTIOUS DISEASE (2020)

Article Medical Laboratory Technology

Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation

Ondrej Pelak et al.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)